6785
昱展新藥
-1.60 (-1.67%)94.0031成交張數–本益比2.64股價淨值比0.11%殖利率2026-09-11資料日期
每股盈餘
柱為單季 EPS,線為近四季合計;近十年
| 季度 | 單季 EPS | 年增 | 近四季 EPS | 歸屬母公司淨利(億) | 淨利率 | ROE(季) | ROE(近四季) |
|---|---|---|---|---|---|---|---|
| 2026Q2 | 0.24 | – | -1.07 | 0.16 | 1246.4% | 0.66% | -2.99% |
| 2026Q1 | -0.53 | – | -1.69 | -0.35 | -14070.8% | -1.47% | -4.64% |
| 2025Q4 | -0.38 | -202.7% | -1.19 | -0.25 | -1696.4% | -1.05% | -3.26% |
| 2025Q3 | -0.40 | – | -0.44 | -0.27 | – | -1.11% | -1.20% |
| 2025Q2 | -0.38 | – | -0.27 | -0.25 | -2000.2% | -1.02% | -0.71% |
| 2025Q1 | -0.03 | -115.8% | 0.05 | -0.02 | – | -0.08% | 0.16% |
| 2024Q4 | 0.37 | – | 0.27 | 0.25 | – | 1.00% | – |
| 2024Q3 | -0.23 | – | – | -0.15 | -261.6% | -0.61% | – |
| 2024Q2 | -0.06 | – | – | -0.04 | – | -0.14% | – |
| 2024Q1 | 0.19 | – | – | 0.12 | – | – | – |